Definitive Contract HT942525CE045
- Not listed
- The Department of the Army Medical Command awarded a $249,977.35 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Tao Treasures, LLC, doing business as Nanobiofab, a minority-owned, self-certified small disadvantaged business, woman-owned small business, and Asian-Pacific American-owned limited liability company located in Frederick, Maryland. The contract, funded under the Defense Health Agency's SBIR program, is for research and development of a "RAPID-INOSE:...
- The Department of the Army Medical Command awarded a $1,099,999.67 definitive contract to Tao Treasures, LLC, doing business as Nanobiofab, for work on Rapid-INOSE: Real-Time Agnostic Patch for Infection Detection Using Intelligent Nose under the Small Business Innovation Research Program Phase II solicitation. The contract is set aside for total small business and will support research and development efforts through December 2025 to deliver a rapid, agnostic patch for infection detection using...
- Tao Treasures, LLC, doing business as Nanobiofab, has been awarded a firm fixed price Small Business Innovation Research Program Phase I contract valued at $249,963 from the Defense Health Agency. The award will support research titled "Inkjet Assisted Nano Printing Sensing Platform for High Throughput Flexible Sensors Discovery" under SBIR topic number H201-003-0047. As a minority-owned, self-certified small disadvantaged woman-owned business, Tao Treasures will utilize the funding to...
- This is a $1,871,326.84 firm fixed price Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Tao Treasures, LLC, doing business as Nanobiofab. Nanobiofab is a minority-owned, self-certified small disadvantaged business, woman-owned small business, and Asian-Pacific American-owned limited liability company located in Frederick, Maryland. The contract is for the development of "WoundSentry," an integrated smart dressing for...
- The Defense Health Agency has awarded a $249,962.26 Small Business Innovation Research (SBIR) Phase I contract to Applied Nanotech, Inc., doing business as Fepet, for the development of MicroBeID, a point-of-care, electronics-free molecular diagnostic platform for microbial detection. The contract, issued as a firm fixed-price purchase order with an ultimate completion date of March 21, 2026, is designated as a total small business set-aside and supports medical research and development...
- Tao Treasures, LLC, doing business as Nanobiofab, has been awarded a $1.6 million firm fixed price contract from the Department of the Army Medical Command to deliver on Phase II of proposal H2-0643 titled "AI-Powered Inkjet Assisted Nano Printing and Screening Platform for High-Throughput Flexible Sensors Discovery." The research will be conducted under the Small Business Innovation Research Program Phase II vehicle. Work will take place in Frederick, Maryland through December 2024....
- This is a SBIR (Small Business Innovation Research) Phase II contract awarded by the Defense Health Agency to Innosense Corporation, a small disadvantaged minority-owned business. The $999,998.59 contract is for research and development work related to the SBIR program. SBIR Phase II contracts provide funding for further development and prototyping of innovative technologies that were initially explored in a Phase I award. The contract is a cost-plus-fixed-fee type, which is common for this type...
- The U.S. Department of Defense's Defense Advanced Research Projects Agency (DARPA) awarded a Small Business Innovation Research (SBIR) Phase I contract to Nano Terra, Inc., a self-certified small disadvantaged business, for $149,987.00. The contract is for a "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES". This is a firm-fixed-price, definitive contract with a period of performance ending on November 30, 2017. The contract was...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Advanced Silicon Group, Inc., a woman-owned small business. The contract, valued at $400,000.00, is for research and development of a biosensor prototype that can detect drugs in postmortem blood samples using coupled acoustical wave micropillar technology. The contract is a firm fixed-price definitive contract with a completion date of...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Innosense Corporation, a small disadvantaged and woman-owned business based in Torrance, California. The $149,998.81 firm-fixed-price contract supports research and development work related to the SBIR topic H161-006-0002. As a Phase I SBIR contract, this award aims to demonstrate the scientific and technical merit and feasibility of a proposed innovative technology...
The Defense Health Agency awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Tao Treasures, LLC, doing business as Nanobiofab, for development of TRISENSE, an artificially intelligent volatile organic compound sensing system designed for culture-free infection diagnosis in biofluids. This total small business set-aside contract, awarded on September 15, 2025, represents a continuation of the SBIR program's support for innovative medical technologies and is scheduled for completion by January 14, 2028. The work will be performed in Frederick, Maryland, where Nanobiofab is headquartered. Nanobiofab is a minority-owned, woman-owned, and Asian-Pacific American-owned small disadvantaged business with a demonstrated track record of developing advanced medical sensing and diagnostic solutions. The company has secured over $5 million in prior federal contracts, primarily from the Defense Health Agency and Department of the Army Medical Command, for innovative technologies including WoundSentry, a smart dressing for burn wound infection detection, and Rapid-INOSE, an intelligent patch for real-time infection detection. The TRISENSE contract leverages Nanobiofab's core competencies in artificial intelligence, nanotechnology, and intelligent sensor platforms to advance non-invasive diagnostic capabilities for military medical applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3m | 9/11/25 |